Bioshares Etf Financials

BBP -  USA Etf  

USD 50.79  0.14  0.28%

Understanding current and past Bioshares Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioshares Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Bioshares Biotech's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Bioshares Biotech's financials over time to get the whole picture.
Use fundamental data analysis to double-check all available reported financial drivers of Bioshares Biotech to find out if markets are presently mispricing the etf. We have analyzed eleven available fundamental indicators for Bioshares Biotech Products, which can be compared to its rivals. Please make use of Bioshares Biotech one year return and equity positions weight to make a decision on whether Bioshares Biotech is priced fairly. Use Bioshares Biotech to enhance returns of your portfolios. The etf experiences a normal upward fluctuation. Check odds of Bioshares Biotech to be traded at $53.33 in 90 days.

Bioshares Fundamentals 

With this module, you can analyze Bioshares financials for your investing period. You should be able to track the changes in Bioshares Biotech individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  Chance Of Financial Distress
Less than 1
Bioshares Biotech Products has less than 1 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Bioshares Biotech etf is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Bioshares Biotech's official financial statements usually reflect Bioshares Biotech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bioshares Biotech. For example, before you start analyzing numbers published by Bioshares accountants, it's critical to develop an understanding of what Bioshares Biotech's liquidity, profitability, and earnings quality are in the context of the Virtus space in which it operates.
Please note, the presentation of Bioshares Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bioshares Biotech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bioshares Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioshares Biotech Products. Please utilize our Beneish M Score to check the likelihood of Bioshares Biotech's management to manipulate its earnings.

Bioshares Biotech Company Summary

Bioshares Biotech competes with SP 500, Healthcare ETF, Nasdaq Biotechnology, Ark Genomic, and US Medical. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Bioshares Biotech is traded on NYSEArca Exchange in the United States.
InstrumentUSA Etf View All
ExchangeNYSEArca Exchange
RegionNorth America
Investment IssuerVirtus
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
Phone888 383 0553
CurrencyUSD - US Dollar
You should never invest in Bioshares Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bioshares Etf, because this is throwing your money away. Analyzing the key information contained in Bioshares Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Bioshares Biotech Key Financial Ratios

Generally speaking, Bioshares Biotech's financial ratios allow both analysts and investors to convert raw data from Bioshares Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Bioshares Biotech over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bioshares Biotech reports annually and quarterly.

Bioshares Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bioshares Biotech's current stock value. Our valuation model uses many indicators to compare Bioshares Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioshares Biotech competition to find correlations between indicators driving Bioshares Biotech's intrinsic value. More Info.
Bioshares Biotech Products is rated below average in one year return as compared to similar ETFs. It is rated below average in net asset as compared to similar ETFs making up about  2,127,592  of Net Asset per One Year Return. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bioshares Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bioshares Biotech's Etf . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioshares Biotech's earnings, one of the primary drivers of an investment's value.

Bioshares Biotech Systematic Risk

Bioshares Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioshares Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Bioshares Biotech correlated with the market. If Beta is less than 0 Bioshares Biotech generally moves in the opposite direction as compared to the market. If Bioshares Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioshares Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioshares Biotech is generally in the same direction as the market. If Beta > 1 Bioshares Biotech moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Bioshares Biotech Financials

What exactly are Bioshares Biotech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Bioshares Biotech's income statement, its balance sheet, and the statement of cash flows. Potential Bioshares Biotech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Bioshares Biotech investors may use each financial statement separately, they are all related. The changes in Bioshares Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bioshares Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Bioshares Biotech is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Bioshares grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
This Etf does not participate in any thematic ideas. You can create a thematic portfolio hereView All Thematic Ideas

Bioshares Biotech October 24, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Bioshares Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioshares Biotech Products. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioshares Biotech Products based on widely used predictive technical indicators. In general, we focus on analyzing Bioshares Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioshares Biotech's daily price indicators and compare them against related drivers.
Information Ratio(0.037645)
Maximum Drawdown6.92
Value At Risk(2.06)
Potential Upside1.91
Continue to Trending Equities. Note that the Bioshares Biotech information on this page should be used as a complementary analysis to other Bioshares Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Bioshares Etf analysis

When running Bioshares Biotech price analysis, check to measure Bioshares Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioshares Biotech is operating at the current time. Most of Bioshares Biotech's value examination focuses on studying past and present price action to predict the probability of Bioshares Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioshares Biotech's price. Additionally, you may evaluate how the addition of Bioshares Biotech to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
The market value of Bioshares Biotech is measured differently than its book value, which is the value of Bioshares that is recorded on the company's balance sheet. Investors also form their own opinion of Bioshares Biotech's value that differs from its market value or its book value, called intrinsic value, which is Bioshares Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioshares Biotech's market value can be influenced by many factors that don't directly affect Bioshares Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioshares Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioshares Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioshares Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.